Name | RO4938581 |
---|---|
Synonyms |
9H-Imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine, 3-bromo-10-(difluoromethyl)-
MFCD28133556 RO4938581 3-Bromo-10-(difluoromethyl)-9H-imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine RO 4938581 |
Description | RO 4938581 is a potent and selective GABAA α5 inverse agonist, with a Ki of 4.6 nM for GABAA α5β3γ2a, and shows a lower affinity at α1β3γ2a, α2β3γ2a, α3β3γ2a (Ki, 174, 185, 80 nM, respectively); RO 4938581 is used in the research of cognitive dysfunction. |
---|---|
Related Catalog | |
Target |
Ki: 4.6 nM (GABAA α5β3γ2a), 174 nM (GABAA α1β3γ2a), 185 nM (GABAA α2β3γ2a), 80 nM (GABAA α3β3γ2a)[1] |
In Vitro | RO 4938581 is a potent and selective GABAA α5 inverse agonist, with a Ki of 4.6 nM for GABAA α5β3γ2a, and shows a lower affinity at α1β3γ2a, α2β3γ2a, α3β3γ2a (Ki, 174, 185, 80 nM, respectively)[1]. |
In Vivo | RO 4938581 (0.3-1 mg/kg, p.o.) reverses a working memory impairment induced by scopolamine the delayed match to position (DMTP) task and a spatial learning impairment induced by diazepam (RO 4938581; 1-10 mg/kg, po)[1]. |
References |
Density | 1.9±0.1 g/cm3 |
---|---|
Boiling Point | 559.8±60.0 °C at 760 mmHg |
Molecular Formula | C13H8BrF2N5 |
Molecular Weight | 352.137 |
Flash Point | 292.4±32.9 °C |
Exact Mass | 350.993103 |
LogP | 2.83 |
Vapour Pressure | 0.0±1.5 mmHg at 25°C |
Index of Refraction | 1.784 |